Used in solid-phase peptide synthesis as a protected amino acid building block, particularly for incorporating a modified phenylalanine residue with enhanced hydrophobic and steric properties. The Fmoc group allows for mild base deprotection, compatible with standard Fmoc-strategy protocols. The 4-methoxyphenyl substituent can influence peptide conformation, stability, or interaction with biological targets, making it useful in the development of bioactive peptides, enzyme inhibitors, or peptidomimetics. Its structure is beneficial in medicinal chemistry research for structure-activity relationship (SAR) studies and in designing peptides with improved metabolic stability or receptor selectivity.